Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Synthesis
Sigma-Aldrich Expands Boronic Acid Deal
by Michael McCoy
August 16, 2010
| A version of this story appeared in
Volume 88, Issue 33
Sigma-Aldrich has signed a licensing agreement with the University of Illinois, Urbana-Champaign, enabling it to expand the range of boronic acid surrogates it can provide chemists for small-molecule synthesis. Since 2008, Sigma-Aldrich has been offering N-methyliminodiacetic acid (MIDA) boronates developed by chemistry professor Martin Burke. The expanded deal provides access to new MIDA-ligated boronates for which the analogous acids are unstable and often difficult to synthesize. Sigma-Aldrich says users get royalty-free access to the university’s intellectual property.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter